MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive impairment in patients with Parkinson’s Disease

E. Kolupaeva, I. Zhukova, N. Zhukova, M. Nikitina, O. Izhboldina, I. Mironova, Z. Kislukhina (Tomsk, Russian Federation)

Meeting: 2019 International Congress

Abstract Number: 1580

Keywords: Cognitive dysfunction, Dementia, Parkinsonism

Session Information

Date: Wednesday, September 25, 2019

Session Title: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Agora 3 West, Level 3

Objective: The objective is to study the relation between cognitive impairment with the form and stage of PD.

Background: Currently, there is a tendency of a global change in the gender and age structure of the population. The proportion of older people in the population is steadily increasing. Cognitive impairment is directly related to age. So from the age of 65 their prevalence doubles every 5 years. Parkinson’s disease plays a big role in the development of dementia.

Method: 287 patients with PD I-IV stage of Hyun and Yar  took part in the study. The average age of the patients is 66.4 ± 9.0 years. All received standard specific anti-parkinsonian pharmacotherapy.  All patients have been evaluated according to the Mini-Mental State Examination (MMSE), the clock-drawing test (CDT) and the Frontal Assessment Batte (FAB).

Results: On the FAB scale, the maximum average was observed in patients with stage I of PD – 15.6 ± 2.6 points and the minimum with stage IV – 13.0 ± 4.1 points. A similar tendency was also revealed when performing the CDT test, where the highest result was observed at stage I of the disease – 8.8 ± 1.7 points, and the lowest at stage IV – 5.9 ± 2.6 points. Patients with a tremor of PD had the highest results of neuropsychological testing and the largest number (45.8%) of people without cognitive impairment (p <0.0001) were recorded, with mixed ones - lower (p <0.0001).

Conclusion: The study has demonstrated that the patients with a tremor of PD had less of their severity cognitive impairment compared with mixed form of PD. Patients with stage I of PD had minimal the severity of cognitive impairment.

To cite this abstract in AMA style:

E. Kolupaeva, I. Zhukova, N. Zhukova, M. Nikitina, O. Izhboldina, I. Mironova, Z. Kislukhina. Cognitive impairment in patients with Parkinson’s Disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/cognitive-impairment-in-patients-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-impairment-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley